Once-Daily Basal Insulin in T2D by Diabetes DurationONWARDS 15 Saturday, June 21
Phase 2 results (48 weeks): 1mg dose: 8.7% average weight loss 4mg dose: 17.1% average weight loss 8mg dose: 22.8% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss These numbers came from a 48-week study period, six months shorter than the 72-week SURMOUNT trials
Estrogens are secreted cyclically, inducing a negative feedback on gonadotropins and modulating the hypothalamic-pituitary-gonadal axis (Jensen et al., 2010)
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of -caryophyllene, a dietary cannabinoid
Annual review of nutrition
Our advantages translate into reliable, high-quality liposomal formulations that accelerate preclinical research and enable successful drug development strategies